Namshik Han’s group at the Milner Therapeutics Institute, have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials. In a study published this week in Science Advances,...
We are excited to announce that the University of Cambridge has launched the Connect: Health Tech microsite and online community platform, as part of the new University Enterprise Zone (UEZ) initiative. The delivery team behind Connect: Health Tech is the Milner...
Last month, the Onco-Innovation Programme — part of the CRUK Cambridge Centre and managed by our own Dr Rebecca Harris — launched a new rapid response data analysis pump prime call. This exciting new call was designed to seek collaborative project proposals from CRUK...
Work at the Milner Therapeutics Institute by Director Tony Kouzarides and Kostas Tzelepis in collaboration with Storm Therapeutics has made a promising step towards developing a new drug for treating acute myeloid leukaemia. In a paper published today in Nature,...
We are excited to announce a new collaboration which has been set up through the Milner Therapeutics Consortium to investigate autophagy targets in neurodegeneration. This is the first such project to bring together multiple academic groups across the University and...
As we reach the end of what has been the most challenging and difficult year so far, we want to take the time to celebrate the achievements of our Affiliated Companies. Despite challenging times there have been some fantastic updates, and you can explore them using...
